Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 grant ...
A Memphis man is standing trial in the murders of his newborn daughter and her mother. Brandon Isabelle appears in court ...